Forest Labs Lowers 2005 Outlook
103249
Forest Laboratories Inc., which makes antidepressants like Celexa and Lexapro, lowered its profit outlook for 2005 as products from generic drug makers are expected to cut into its sales during the year.
663139
Forrester Research is scaling back its projections for IT spending growth in the first part of 2008, saying spending patterns next year could look a lot like 2007.
632743
The company announces a disappointing quarter and reduces full-year guidance.
322772
Forrester Research has revised projections for IT investment in 2008 down from previous research published in October, predicting the year ahead will be a slow one both in the U.S. and globally.
109240
A leading forecaster of advertising spending has again lowered his estimate for growth in the U.S. this year.
407849
Citing a possible mild U.S. recession, Forrester Research has downgraded its information technology spending outlook.
203128
The deep-discount retailer misses earnings projections and lowers its outlook.
527123
Bookseller Borders Group Inc.  BGP.N on Tuesday slashed its financial forecast, saying sales  were weaker than expected due in part to hurricanes, and that  profits during the key holiday season would miss Wall Street  estimates.
301253
Forrester Research said Monday that it is downgrading its 2008 forecast for IT purchasing in both the U.S. and around the world.
90262
Forest Laboratories Inc. (FRX.N: Quote, Profile, Research) on Tuesday said its experimental hypertension drug failed to meet all its goals in an effectiveness study, an outcome that will delay development and may lead to a new trial.
502562
Shares of chip design software company Magma Design Automation Inc. fell Wednesday as the company reiterated its second-quarter outlook but lowered its guidance for the year.
666385
Shares of Forest Laboratories (FRX:NYSE - news - research)slipped Tuesday after the company said a test of an experimental blood pressure drug didn&#39;t meet all of the study&#39;s goals.
538251
A much-watched Alzheimer&#39;s medicine Forest Laboratories (nyse: FRX - news - people ) was developing with Germany&#39;s Merz failed to show a statistically significant benefit in a clinical trial.
551163
Stocks to watch on Wednesday: FOREST LABORATORIES INC. (FRX.N: Quote, Profile, Research). The drug company&#39;s experimental treatment for Alzheimer&#39;s failed to prove effective in a big clinical trial.
286897
Analysts lower revenue projections for contract chip makers to 5.1 percent.
341742
Shares dropped as the company forecast a decline in 2008 earnings due to generic competition and weaker sales for its diabetes pill.
340802
Prices of computer screens are expected to fall by less than 5 percent in the fourth quarter as the market stabilizes on hopes of a pick-up in demand during the Christmas season, a U.S.-based research firm said on Tuesday.